SSRIs are often the first choice for treating depression and various anxiety disorders. Medications for anxiety and depression work by boosting neurotransmitters like serotonin, norepinephrine, ...

Managed care organizations must prioritize dextromethorphan-bupropion based on sustained efficacy, improved remission rates, ...

In everyday language, the word depression is used in diverse ways and can refer to anything from passing feelings of sadness and unhappiness to chronic grief and deep despair. When clinicians and ...

Dextromethorphan, often taken as a cough suppressant, is now approved to treat major depressive disorder (MDD) in combination with bupropion. A clinical trial found that dextromethorphan/bupropion ...

For some, the holidays, a time most see as a time of joy, can be a difficult season, and mental health experts are pointing ...

The majority of individuals treated for major depressive disorder continue to report some depressive symptoms even after six weeks of treatment, and about 30 percent are considered to be treatment ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

ECT can seem like something out of science fiction, but it actually has decades of studies to show how effective it can be in reducing depression symptoms. Depression is one of the most common mental ...

—Researchers recently examined the impact of depressive symptoms, as measured by the 21-item Beck Depression Inventory, on adherence to therapy using correlation, network analysis, and linear ...